Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti-IL2 Receptor Monoclonal Antibodies?

Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study

(2015) R. Hellemans et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance

(2015) B. Tanriover et al.   Clinical Journal of the American Society of Nephrology

Rabbit antithymocyte globulin induction and risk of post-transplant lymphoproliferative disease in adult and pediatric solid organ transplantation: An update

(2015) Alexandre Hertig et al.   TRANSPLANT IMMUNOLOGY

Association of Antibody Induction Immunosuppression With Cancer After Kidney Transplantation

(2015) Erin C. Hall et al.   TRANSPLANTATION

Alefacept Combined With Tacrolimus, Mycophenolate Mofetil and Steroids inDe NovoKidney Transplantation: A Randomized Controlled Trial

(2013) L. Rostaing et al.   AMERICAN JOURNAL OF TRANSPLANTATION

OSAKA Trial

(2013) Laetitia Albano et al.   TRANSPLANTATION

Epidemiology of Posttransplant Lymphoproliferative Disorders in Adult Kidney and Kidney Pancreas Recipients: Report of the French Registry and Analysis of Subgroups of Lymphomas

(2012) S. Caillard et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Influence of Induction Modality on the Outcome of Deceased Donor Kidney Transplant Recipients Discharged on Steroid-Free Maintenance Immunosuppression

(2012) Kalathil K. Sureshkumar et al.   TRANSPLANTATION

Tacrolimus-Based, Steroid-Free Regimens in Renal Transplantation

(2012) Bernhard K. Krämer et al.   TRANSPLANTATION

Very early steroid withdrawal or complete avoidance for kidney transplant recipients: a systematic review

(2011) J. Pascual et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Posttransplantation Lymphoproliferative Disorder in Kidney and Heart Transplant Recipients Receiving Thymoglobulin: A Systematic Review

(2011) W.H. Marks et al.   TRANSPLANTATION PROCEEDINGS

The Impact of IL2ra Induction Therapy in Kidney Transplantation Using Tacrolimus- and Mycophenolate-Based Immunosuppression

(2010) Jane Gralla et al.   TRANSPLANTATION

Daclizumab versus Antithymocyte Globulin in High-Immunological-Risk Renal Transplant Recipients

(2009) C. Noel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients

(2009) WAI H LIM et al.   NEPHROLOGY

Influence of Immunosuppressive Regimens on Graft Survival and Secondary Outcomes After Kidney Transplantation

(2009) Gerhard Opelz et al.   TRANSPLANTATION

Early Outcomes of Thymoglobulin and Basiliximab Induction in Kidney Transplantation: Application of Statistical Approaches to Reduce Bias in Observational Comparisons

(2009) Lisa M. Willoughby et al.   TRANSPLANTATION

Induction With and Without Antithymocyte Globulin Combined With Cyclosporine/Tacrolimus-Based Immunosuppression in Renal Transplantation: A Meta-analysis of Randomized Controlled Trials

(2009) J.H. Tian et al.   TRANSPLANTATION PROCEEDINGS

Long-Term Results of Rabbit Antithymocyte Globulin and Basiliximab Induction

(2008) Daniel C. Brennan et al.   NEW ENGLAND JOURNAL OF MEDICINE